Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2024-519625-38-00Phase 3Completed
Phase 3, randomised, double-blind trial of fentanyl in postoperative pain (3 arms), sponsored by CCDRD. Primary endpoint: Survival distribution to trial termination for inadequate analgesia within 24 hours. Started Apr 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2024-519625-38-00.